The CAF also promoted dyslipidemia, a MetS comorbidity, especially in the L18 condition, since these rats showed increased serum levels of cholesterol, triglycerides, and NEFA, as well as glucose and insulin. The gene discussed is INS; the disease is metabolic syndrome.